EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor

Iftikhar Khan iD, Ali Al-Hasani, Mohsin H Khan, Aamir N Khan, Fakhr-E -Alam, Sajid K Sadozai, Abdelbary Elhissi, Jehanzeb Khan, Sakib Yousaf

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Iftikhar Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom. Hauptthemen laut MEDLINE: Beclomethasone, Lactose. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug delivery via aerosolization for localized and systemic effect is a non-invasive approach to achieving pulmonary targeting. The aim of this study was to prepare spray-dried proliposome (SDP) powder formulations to produce carrier particles for superior aerosolization performance, assessed via a next generation impactor (NGI) in combination with a dry powder inhaler. SDP powder formulations (F1-F10) were prepared using a spray dryer, employing five different types of lactose carriers (Lactose monohydrate (LMH), lactose microfine (LMF), lactose 003, lactose 220 and lactose 300) and two different dispersion media. The first dispersion medium was comprised of water and ethanol (50:50% v/v ratio), and the second dispersion medium comprised wholly of ethanol (100%). In the first dispersion medium, the lipid phase (consisting of Soya phosphatidylcholine (SPC as phospholipid) and Beclomethasone dipropionate (BDP; model drug) were dissolved in ethanol and the lactose carrier in water, followed by spray drying. Whereas in second dispersion medium, the lipid phase and lactose carrier were dispersed in ethanol only, post spray drying. SDP powder formulations (F1-F5) possessed significantly smaller particles (2.89 ± 1.24–4.48 ± 1.20 μm), when compared to SDP F6-F10 formulations (10.63 ± 3.71–19.27 ± 4.98 μm), irrespective of lactose carrier type via SEM (scanning electron microscopy). Crystallinity of the F6-F10 and amorphicity of F1-F15 formulations were confirmed by XRD (X-ray diffraction). Differences in size and crystallinity were further reflected in production yield, where significantly higher production yield was obtained for F1-F5 (74.87 ± 4.28–87.32 ± 2.42%) then F6-F10 formulations (40.08 ± 5.714–54.98 ± 5.82%), irrespective of carrier type. Negligible differences were noted in terms of entrapment efficiency, when comparing F1-F5 SDP formulations (94.67 ± 8.41–96.35 ± 7.93) to F6-F10 formulations (78.16 ± 9.35–82.95 ± 9.62). Moreover, formulations F1-F5 demonstrated significantly higher fine particle fraction (FPF), fine particle dose (FPD) and respirable fraction (RF) (on average of 30.35%, 890.12 μg and 85.90%) when compared to counterpart SDP powder formulations (F6-F10). This study has demonstrated that when a combination of water and ethanol was employed as dispersion medium (formulations F1-F5), superior formulation properties for pulmonary drug delivery were observed, irrespective of carrier type employed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BeclomethasoneLactosePowdersParticle SizeAdministration, InhalationDry Powder InhalersEthanolWaterLipidsAerosolsDrug Carriers

Substanzen

BeclomethasonePowdersLactoseEthanolWaterLipidsAerosolsDrug Carriers

Autor:innen und Institutionen

  • School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
  • Surgical A Ward, Khyber Teaching Hospital, Peshawar, Pakistan.
  • Cardiology Department, Lady Reading Hospital, Peshawar, Pakistan.
  • Department of Hepatology, King's College Hospital, Denmark Hill, London, United Kingdom.
  • Department of Pharmacy, Kohat University of Science and Technology, Kohat, Pakistan.
  • Pharmaceutical Sciences Section, College of Pharmacy, Qatar University, Doha, Qatar.

ORCID-Profile: Iftikhar Khan

Zitieren

APA

Khan, I., Al-Hasani, A., Khan, M. H., Khan, A. N., -Alam, F. E., Sadozai, S. K., Elhissi, A., Khan, J., & Yousaf, S. (2023). Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor. PLOS ONE. https://doi.org/10.1371/journal.pone.0281860

Vancouver

Khan I, Al-Hasani A, Khan MH, Khan AN, -Alam FE, Sadozai SK, et al. Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor. PLOS ONE. 2023. doi:10.1371/journal.pone.0281860

BibTeX
@article{Khan2023,
  author = {Khan, Iftikhar and Al-Hasani, Ali and Khan, Mohsin H and Khan, Aamir N and -Alam, Fakhr-E and Sadozai, Sajid K and Elhissi, Abdelbary and Khan, Jehanzeb and Yousaf, Sakib},
  title = {Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281860}
}
Kostenlos starten →